Related references
Note: Only part of the references are listed.Multiple Factors Confer Specific Cdc42 and Rac Protein Activation by Dedicator of Cytokinesis (DOCK) Nucleotide Exchange Factors
Kiran Kulkarni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Targeting transcription factor NFκB Comparative analysis of proteasome and IKK inhibitors
Alexander V. Gasparian et al.
CELL CYCLE (2009)
Rac1 GTPase: A Rac of All Trades
E. E. Bosco et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer
Yang Liu et al.
LUNG CANCER (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Ect2 links the PKCι-Par6α complex to Rac1 activation and cellular transformation
V. Justilien et al.
ONCOGENE (2009)
The Activated NF-kappa B-Snail-RKIP Circuitry in Cancer Regulates Both the Metastatic Cascade and Resistance to Apoptosis by Cytotoxic Drugs
Katherine Wu et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
NF-κB in carcinoma therapy and prevention
Matthew Brown et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division
David Michaelson et al.
JOURNAL OF CELL BIOLOGY (2008)
The role of nuclear factor kappa B in pancreatic cancer and the clinical applications of targeted therapy
Bryan Holcom et al.
PANCREAS (2008)
Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of rac family small GTPases
Adam Shutes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch
Gitanjali Jayachandran et al.
CANCER RESEARCH (2007)
Requirement for Rac1 in a K-ras-induced lung cancer in the mouse
Joseph L. Kissil et al.
CANCER RESEARCH (2007)
Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth
Yuki Miyamoto et al.
EXPERIMENTAL CELL RESEARCH (2007)
Rac signaling in tumorigenesis and as target for anticancer drug development
Di Sun et al.
DRUG RESISTANCE UPDATES (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1
Kei Miyano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1
Leni Moldovan et al.
CARDIOVASCULAR RESEARCH (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
RAC1 inhibition targets amyloid precursor protein processing by γ-secretase and decreases Aβ production in vitro and in vivo
L Désiré et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Involvement of the muscarinic acetylcholine receptor in inhibition of cell migration
KA Varker et al.
BIOCHEMICAL PHARMACOLOGY (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
Regulation of c-myc expression by PDGF through Rho GTPases
M Chiariello et al.
NATURE CELL BIOLOGY (2001)
Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IκBβ
YX Jiang et al.
ONCOGENE (2001)
Toll-like receptor 2-mediated NF-κB activation requires a RacI-dependent pathway
L Arbibe et al.
NATURE IMMUNOLOGY (2000)
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer et al.
ONCOGENE (2000)
Vav2 is an activator of Cdc42, Rac1, and RhoA
K Abe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
